Alerts will be sent to your verified email
Verify Email
AKUMS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, the company owns the intellectual property for the manufacturing processes of several of its formulations, and its core business is focused on providing end-to-end product development and manufacturing solutions to its clients.
Akums Drugs & Pharma major competitors are Shilpa Medicare, Aarti Pharmalabs, Acutaas Chemicals, Strides Pharma Scien, FDC, Procter&Gamble Healt, Medplus Health Servi.
Market Cap of Akums Drugs & Pharma is ₹8,446 Crs.
While the median market cap of its peers are ₹8,470 Crs.
Akums Drugs & Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May | Jun Sep Dec | ||||||||||||||||
| Investor Presentation | May | Jun Sep Dec | ||||||||||||||||
| Conference Call | Mar | Sep Dec | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
